Form 4: Royalty Pharma Director Henry A. Fernandez Acquires Shares in Lieu of Retainer

Director Henry A. Fernandez acquired 1,240 Class A Ordinary Shares of Royalty Pharma plc in lieu of a quarterly retainer payment.

Summary

• On March 28, 2024, Henry A. Fernandez, a director of Royalty Pharma plc, acquired 1,240 Class A Ordinary Shares.
• The shares were issued under the Issuer's 2020 Independent Director Equity Incentive Plan.
• The acquisition was in lieu of a quarterly retainer payment of $37,500, with the shares acquired at a price of $30.2283 each.
• Following the transaction, Fernandez directly owns 41,968 Class A Ordinary Shares.
• Fernandez also indirectly owns 58,200 Class A Ordinary Shares through the Fernandez 2007 Children's Trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, indicating confidence in the company's future. The use of equity in lieu of cash is also a prudent financial decision.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The use of equity in lieu of cash preserves company cash flow.

Industry Context

Director share acquisitions are common and often viewed positively by investors as they align management's interests with those of shareholders. Using equity for compensation is a common practice in the pharmaceutical industry.

Comparison to Industry Standards

• Comparing Royalty Pharma's director compensation structure to companies like Gilead Sciences, Amgen, and AbbVie, it's common to see a mix of cash and equity-based compensation.
• The specific amount and type of equity grants can vary widely based on company size, performance, and individual director roles.
• Equity grants in lieu of cash retainers are a fairly standard practice to conserve cash and align director incentives with shareholder value.

Stakeholder Impact

• Shareholders may view the director's share acquisition positively.
• The company benefits from preserving cash by issuing shares instead of making a cash payment.

Key Dates